Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin

BACKGROUND: Treatment with daunorubicin (DNR) in acute myeloid leukemia is moderately effective and associated with significant side effects, including cardiac toxicity. We recently developed a nanomicellar formulation of DNR that specifically targets acute myeloid leukemia stem cells. MATERIALS &am...

詳細記述

保存先:
書誌詳細
主要な著者: Zhang, Hongyong, Li, Yuanpei, Lin, Tzu-yin, Xiao, Kai, Haddad, Ashraf S, Henderson, Paul T, Jonas, Brian A, Chen, Mingyi, Xiao, Wenwu, Liu, Ruiwu, Lam, Kit S, Pan, Chong-xian
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167557/
https://ncbi.nlm.nih.gov/pubmed/24628688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.14.44
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料